True Wealth Design’s Pacira BioSciences PCRX Stock Holding History

True Wealth Design’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.65K	Hold	341	–	–	﹤0.01%	1115
2026 Q1	$7.71K	Hold	341	–	–	﹤0.01%	1062
2025 Q4	$8.83K	Hold	341	–	–	﹤0.01%	910
2025 Q3	$8.79K	Hold	341	–	–	﹤0.01%	883
2025 Q2	$8.15K	Hold	341	–	–	﹤0.01%	647
2025 Q1	$8.47K	Hold	341	–	–	﹤0.01%	521
2024 Q4	$6.42K	Buy	341 +78	+30%	+$1.37K	﹤0.01%	491
2024 Q3	$3.96K	Buy	+263	New	+$4.5K	﹤0.01%	617

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

True Wealth Design's PCRX Position: Q2 2026 in Review

True Wealth Design held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 341 shares worth $8.65K. The position accounts for ﹤0.01% of the portfolio, ranked #1115.

True Wealth Design first reported a position in PCRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $8.83K in Q4 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

True Wealth Design held 341 shares of Pacira BioSciences worth $8.65K as of Q2 2026.
True Wealth Design left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up ﹤0.01% of True Wealth Design's portfolio in Q2 2026, its #1115 holding.
True Wealth Design first reported a position in Pacira BioSciences in Q3 2024 and has held it in 8 quarters since.
True Wealth Design's Pacira BioSciences position peaked at $8.83K in Q4 2025.
253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.